Male Contraceptive Injection: The Promise and Potential of RISUG
International Journal of Science and Research (IJSR)

International Journal of Science and Research (IJSR)
Call for Papers | Fully Refereed | Open Access | Double Blind Peer Reviewed

ISSN: 2319-7064


Downloads: 2 | Views: 194 | Weekly Hits: ⮙1 | Monthly Hits: ⮙2

Informative Article | Medical Surgical | India | Volume 13 Issue 10, October 2024 | Popularity: 4.9 / 10


     

Male Contraceptive Injection: The Promise and Potential of RISUG

Dr. Lipica Das


Abstract: Reversible Inhibition of Sperm Under Guidance RISUG is an innovative male contraceptive method involving a nonhormonal injection that blocks sperm flow through the vas deferens. This simple, long - lasting, and minimally invasive procedure is currently undergoing Phase III clinical trials in India, where it has shown a 96100% effectiveness in preventing pregnancy. RISUG offers several benefits, including reversibility and duration of up to 1015 years from a single injection. Although it holds great promise, challenges such as public acceptance, regulatory approval, and long - term efficacy remain. Ongoing research may transform the landscape of male contraception globally.


Keywords: male contraceptive, RISUG, sperm inhibition, reversible contraception, long - term contraception


Edition: Volume 13 Issue 10, October 2024


Pages: 548 - 549


DOI: https://www.doi.org/10.21275/SR241004141408



Make Sure to Disable the Pop-Up Blocker of Web Browser


Text copied to Clipboard!
Dr. Lipica Das, "Male Contraceptive Injection: The Promise and Potential of RISUG", International Journal of Science and Research (IJSR), Volume 13 Issue 10, October 2024, pp. 548-549, https://www.ijsr.net/getabstract.php?paperid=SR241004141408, DOI: https://www.doi.org/10.21275/SR241004141408